DEXTROSE INJECTION,

The Defense Logistics Agency awarded a delivery order under master contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of one box of Dextrose Injection (NSN 6505010170338, NDC 00409-6648-02) at a total contract value of $47.65. The award was issued on July 14, 2026, with a specified delivery date of July 29, 2026, to the address BLDG 6252 42ND ST, FORT CAMPBELL KY 42223-5565 under the identification W91LCR. The transaction is governed by FOB Destination terms, meaning the contractor is responsible for delivery costs and all risks during transit, with inspection and acceptance occurring at the destination. No variance in quantity is permitted, and substitution follows applicable Medical Substitution guidelines. The National Stock Number and manufacturer CAGE code 86491 are included for traceability, alongside the Transportation Control Number W91LCR51980287 for shipment documentation. Packaging instructions require traceable shipping methods, prohibiting parcel post, but no specific preservation standards, barcoding requirements, or MIL-STD references are detailed. No FAR clauses, Section K certifications, socioeconomic representations, or evaluation factors were explicitly included in the documentation. Administrative details such as payment office, contracting officer, COR/COTR contacts, invoicing method, or appropriation codes were not provided, though DIC A0A and PR 7017499312 are listed for financial tracking. The acquisition appears consistent with a Low Price Technically Acceptable procurement under FAR Part 15, typical for low-value commercial pharmaceutical items. The contract is a fixed-quantity, single-line-item award with no options or extensions, derived from a delivery order under a broader government-wide acquisition contract vehicle.